Safety and Tolerance of Immunomodulating Therapy With Donor-specific MSC in Pediatric Living-Donor Liver Transplantation

NCT02957552 · clinicaltrials.gov ↗

PHASE1

Phase

UNKNOWN

Status

7

Enrollment

OTHER

Sponsor class

Conditions

Pediatric Liver Transplantation

Interventions

BIOLOGICAL: Mesenchymal Stem Cells

Sponsor

University Hospital Tuebingen